Related Experiment Video
Updated: Jun 8, 2025
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
Flavonoids as Chemosensitizers in Leukemias
Nigar Huseynova1,2, Melisa Çetinkaya3, Züleyha Baran4
1Department of Biophysics and Biochemistry, Baku State University, Baku, Azerbaijan.
Advances in Experimental Medicine and Biology
|November 6, 2024
Summary
Flavonoids, natural compounds from plants, show promise as anticancer agents by enhancing chemotherapy effectiveness and potentially reducing side effects, especially for leukemia treatment.
Area of Science:
- Phytochemistry and Natural Products
- Oncology and Cancer Therapeutics
- Molecular Biology and Signaling Pathways
Background:
- Flavonoids are diverse phytonutrients found in plants, known for their antioxidant, anti-inflammatory, and anticancer properties.
- These natural compounds play a role in regulating cellular signaling pathways, crucial for understanding their therapeutic potential.
- Current cancer treatments, including chemotherapy, often have significant side effects, necessitating exploration of complementary strategies.
Purpose of the Study:
- To explore the potential of flavonoid nutraceuticals as anticancer agents, particularly in the context of leukemia.
- To investigate the integration of flavonoids with traditional chemotherapy for enhanced cancer treatment outcomes.
- To understand how flavonoids influence cellular signaling pathways relevant to cancer therapy.
Main Methods:
- Review of existing literature on flavonoid biological activities and their mechanisms of action in cancer.
- Analysis of flavonoid's role in modulating cellular signaling pathways involved in cancer progression.
- Exploration of chemosensitization properties of flavonoids and their potential to enhance chemotherapy efficacy.
Main Results:
- Flavonoids exhibit anticancer properties by interfering with key cancer signaling pathways and molecules.
- Evidence suggests flavonoids can act as chemosensitizers, increasing cancer cell responsiveness to chemotherapy.
- Flavonoids hold promise for a cost-effective approach to cancer therapeutics, potentially reducing chemotherapy side effects.
Conclusions:
- Integrating flavonoid nutraceuticals with chemotherapy presents a promising strategy for developing novel anticancer treatments, especially for leukemia.
- Further research into flavonoid-chemotherapy combinations could lead to improved treatment efficacy and reduced toxicity.
- Flavonoids represent a valuable area for developing adjunct cancer therapies with significant potential benefits.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:10Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149